DEXA bone densitometer Horizon®

fan beam

Dual-energy X-ray Absorptiometry (DXA) is the gold-standard technology for measuring bone mineral density and assessing fracture risk. Our DXA system delivers fast, precise, and low-dose scans, helping clinicians detect osteoporosis early, monitor treatment over time, and support proactive bone health management for every patient. Powerful images. Clear answers. Fast Exams Bone density scans are completed in about 10–30 seconds1, and body composition assessments as little as 2 minutes2. Patient-focused design Supports patients weighting up to 500 pounds and offers 24-inch C-arm clearance to help accommodate a wide range of body types and mobility needs. Long term precision Horizon delivers pixel-by-pixel calibration through bone and tissue for greater long-term measurements stability12. Exceptional Image Quality OnePass™ single sweep scanning designed to eliminate beam overlap errors and image distortion. Breast Cancer and Bone Density Breast cancer treatment can significantly impact bone health—patients may lose 6–7% of bone density during therapy13. Aromatase inhibitors, a common endocrine therapy for postmenopausal patients with HR+, early-stage breast cancer, can further accelerate bone loss and increase fracture risk. The Breast Cancer Index® test helps determine whether a patient is likely to benefit from extending endocrine therapy beyond 5 years. When extended therapy is unlikely to help, she may be able to avoid additional exposure to bone toxicity and its impact on long-term bone health. Osteoporosis Assessment Osteoporosis assessment is the process of evaluating bone health